The molecules of life, DNA, replicate with astounding precision, yet this process is not immune to mistakes and can lead to mutations.
Contract manufacturer CordenPharma, recently tapped in a German push to earmark mRNA vaccine capacity, is getting a new owner.
Biogen’s yearlong struggle with the controversial FDA approval and launch of Aduhelm has culminated in a deep overhaul reaching all the way to the CEO.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.